Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
HZNP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 1.37%72.655.8%$206.50m
VRXValeant Pharmaceuticals International, Inc. -1.59%17.3814.1%$102.27m
CTLTCatalent, Inc. 3.53%87.902.2%$79.47m
BHCBausch Health Cos., Inc. -1.59%17.380.0%$78.95m
JAZZJazz Pharmaceuticals Plc -2.06%120.142.4%$74.46m
PRGOPerrigo Co. Plc 0.36%53.166.8%$49.12m
ICPTIntercept Pharmaceuticals, Inc. 1.64%53.4417.2%$47.13m
GWPHGW Pharmaceuticals Plc -0.73%109.006.2%$45.10m
ARGXargenx SE 1.45%232.140.0%$43.61m
TNXPTonix Pharmaceuticals Holding Corp. -12.68%0.890.5%$42.24m
ICLRICON plc 1.09%189.944.3%$41.31m
PCRXPacira Biosciences, Inc. 2.10%61.2210.2%$41.14m
MYOKMyoKardia, Inc. 0.50%101.521.8%$39.58m
AMRNAmarin Corp. Plc 0.46%6.621.5%$39.52m
VRNAVerona Pharma Plc 0.39%7.780.0%$36.83m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.